At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 25 enrolled
Drug / intervention
Zileuton extended releasedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Single-Center, Open-Label, Single-Dose Evaluation of the Duration and Extent of Bronchodilation Following Administration of Zileuton CR 1200 mg in Subjects With Stable, Chronic Asthma
In Brief
A Phase 4 clinical trial evaluating Zileuton extended release for Asthma. Completed, enrolled 25 participants across 1 site.
Detailed Summary
Study to evaluate the bronchodilator effects of Zyflo CR in patients with chronic stable asthma.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAsthma
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartMar 2013
First PostedMar 2013
Primary CompletionJun 2013
TodayJul 2026
First PostedMar 6, 2013
Enrollment StartMar 1, 2013
Primary CompletionJun 1, 2013
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 13.3 years ago
Interventions
Zileuton extended releasedrug